Skip to main content Scroll Top
Most Viewed Posts
Clear Filters
REGEnLIFE: a revolution in the treatment of neurodegenerative diseases
The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis
A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance

MedInTechs 2026 – Parc Floral de Paris | 9 & 10 March

Presentation of REGEnLIFE’s R&D activities, focusing on its technologies, how they work, and its medical innovations aimed at new practical applications. (La French Tech Paris-Saclay / French Tech Méditerranée stand)

Participation in the MedInTechs Society Congress / Healthy Ageing Session – 9 March at 2.50 pm

Oral presentation on the Light4Life clinical trial evaluating our medical device for neuro-intestinal stimulation in Alzheimer’s disease.

Speaker: Guillaume Blivet

MedInTechs 2026
Share this article